Showing results (41-50 of 348) with videos related to
Sort By:
Pageof 35
The Journal of Clinical Psychiatry|January 30, 2020
Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and SchizophreniaJoseph P McEvoy, Daniel E KremensThe Journal of Clinical Psychiatry|October 1, 1979
Case studies in neuropsychiaatry. II: Conversion pseudodementiaJ P Mcevoy, C E WellsThe Journal of Clinical Psychiatry|March 6, 2018
What You Should Know About Tardive Dyskinesia: Screening, Causes, and New Treatment OptionsJ Sloan Manning, Joseph P McEvoyThe Biochemical Journal|December 1, 1996
Inhibition of collagen-induced platelet aggregation as the result of cleavage of alpha 2 beta 1-integrin by the snake venom metalloproteinase jararhaginA S Kamiguti, C R Hay, M ZuzelHaemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Didanosine treatment of haemophilic patients infected with HIVJ T Wilde, A McKernan, C R HayThrombosis and Haemostasis|January 10, 1998
The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre studyC R Hay, C Negrier, C A LudlamLancet (London, England)|June 5, 1982
Effect of fish oil on platelet kinetics in patients with ischaemic heart diseaseC R Hay, A P Durber, R SaynorHaemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
A post-marketing safety and efficacy assessment of a monoclonal antibody purified high-purity factor VIII concentrateC R Hay, C A Lee, G SavidgeBritish Journal of Haematology|January 1, 1983
Idiopathic autoantibody that inhibits fibrin monomer polymerizationS Ghosh, P McEvoy, B A McVerryClinical Therapeutics|January 1, 1987
Replacement of chronically administered anticholinergic drugs by amantadine in outpatient management of chronic schizophreniaJ P McEvoy, M McCue, S FreterPageof 35